Form 4 for CAH Cardinal Health
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0000721371-22-000081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | CAH | CRAWFORD VICTOR L. | CEO, Pharmaceutical Segment | A - Grant | $0.00 | +17.1K | 135.7K | +14% | $0 | |
| 2022-08-17 | 2022-08-15 | CAH | CRAWFORD VICTOR L. | CEO, Pharmaceutical Segment | F - Tax | $69.32 | -30.0K | 105.7K | -22% | -$2.08M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-08-15 | A | A | 17,150 | $0.00 | 135,651 | D | — | — | |
| 2 | Common | Common Shares | 2022-08-15 | F | D | 29,952 | $69.32 | 105,699 | D | — | — | (F3) Reflects closing price on prior business day. |